Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

TAP and Ilyang sign licensing agreement for ilaprazole

Sep. 13, 2005

Progenics updates methylnaltrexone progress

Sep. 13, 2005

New agents for treating hepatitis C infection disclosed by Japan Tobacco

Sep. 12, 2005

Novel HCV-NS3 protease inhibitor enters clinical development

Sep. 9, 2005

TAP terminates license of Flamel technology for delivery of lansoprazole

Sep. 7, 2005

Antileukinate protects mice against cerulein-induced acute pancreatitis

Sep. 7, 2005

XTLbio signs license and asset purchase agreement with VivoQuest

Sep. 6, 2005

Therapeutic agents for gastrointestinal disorders claimed in patent literature

Sep. 5, 2005

Teduglutide benefits short bowel syndrome patients in phase II study

Sep. 2, 2005

Novel selective alpha4beta7/MAdCAM-1 antagonist reduces inflammation in mice with colitis

Sep. 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...